# Impact of iv Dexamethasone on Reversal of Rocuronium-induced Neuromuscular Block by Sugammadex

> **NCT02562417** · PHASE4 · WITHDRAWN · sponsor: **Centre Hospitalier Universitaire Vaudois**

## Conditions studied

- Neuromuscular Blockade

## Interventions

- **DRUG:** Normal saline
- **DRUG:** IV dexamethasone

## Key facts

- **NCT ID:** NCT02562417
- **Lead sponsor:** Centre Hospitalier Universitaire Vaudois
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-06
- **Primary completion:** 2018-05
- **Final completion:** 2018-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Change of practice in the department
- **Last updated:** 2017-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02562417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02562417, "Impact of iv Dexamethasone on Reversal of Rocuronium-induced Neuromuscular Block by Sugammadex". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02562417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*